Methodology

All entries for: Vanda Pharmaceuticals Inc.

August 26, 2025

Vanda Pharmaceuticals Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of polycythemia vera

Disease Area: Rare Diseases